LONDON, U.K. -- Roots Analysis has announced the addition of ‘Biopharmaceutical Contract Manufacturing Market, 2015-2025’ report to their offering. The report provides an extensive study of the contract manufacturing opportunity for this rapidly expanding market. It identifies various CMOs active in this space, their capabilities with respect to manufacturing of biopharmaceuticals (types of biologics manufactured, expression systems used, type of bioreactor and fermentation capacity), scale of operation (clinical/commercial) and geographic location/spread of the facilities. The focus of this report is primarily to understand the likely future evolution of biopharmaceutical contract manufacturing market over the next decade, segmented on the basis of business operations, type of expression systems and key regions.
Shefali Asija, the principal analyst, said, “Owing to a strong pipeline and complexity associated with manufacturing, the biopharmaceutical industry has garnered the interest of a lot of CMOs. Niche sectors such as ADCs and bispecific antibodies characterised by untapped potential and huge growth prospects serve as the potential demand segments for CMOs; rapidly emerging market for biosimilars is yet another encouraging factor.”
The report examines insights gathered from interviews of important stakeholders such as FUJIFILM Diosynth Biotechnologies, Goodwin Biotechnology, Rentschler, Novasep, Piramal Pharma Solutions and Catalent. Asija further stated, “Majority of our work is supported by detailed research. For the purposes of this report, we studied close to 110 collaborations which have taken place over the past few years. The success of the market lies in the intensifying framework of investment activity and technological advancements.”
Key topics covered in the latest report are:
- Analysis of contract manufacturers involved in biopharmaceutical manufacturing
- Future market evolution
- Profiles of leading companies in developed and emerging regions
- Focus on niche segments including ADCs, bispecific antibodies and gene therapy
- Outsourcing outlook for biosimilars
- Recent deals and partnerships
- Investment programs
Who will benefit from this report?
This research is targeted towards biopharma companies and CMOs working in the field of biopharmaceuticals. In particular, you will benefit if you are an:
- Investor
- Contract Manufacturer
- R&D Manager
- Business Intelligence / Scientific Analyst
- Licensing / Portfolio Manager
- Strategy Manager
For additional details and/or to request sample pages, please visit http://www.rootsanalysis.com/reports/market-reports/view_...
About Roots Analysis
Roots Analysis is a specialist market research company, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.
Contact
Roots Analysis
info@rootsanalysis.com
